Falmouth Hematology Oncology Center is categorized under Doctors in Mashpee, MA and active since 2002.
Falmouth Hematology Oncology Center was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Victor Aviles at the company’s single location by writing to 5 Industrial Drive # 206, Mashpee, Massachusetts MA 02649 or by phoning (508) 539-6210. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Falmouth Hematology Oncology Center |
| Contact Person: | Victor Aviles |
| Address: | 5 Industrial Drive # 206, Mashpee, Massachusetts 02649 |
| Phone Number: | (508) 539-6210 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Falmouth Hematology Oncology Center was started in 2002 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Victor Aviles for inquiries that concern Falmouth Hematology Oncology Center by calling the company number (508) 539-6210, as your correspondence is most welcome. Additionally, the physical location of the single location of Falmouth Hematology Oncology Center can be found at the coordinates 41.604724,-70.495087 as well as the street address 5 Industrial Drive # 206 in Mashpee, Massachusetts 02649.
For its online presence, you may visit Falmouth Hematology Oncology Center’s website at and engage with its social media outlets through on Twitter and on Facebook.